3551 - 3600 of 9038 Results
Title
Year
-
OPENTitle: Targeting specific kinase substrates rescues increased colitis severity induced by the Crohn’s disease–linked LRRK2-N2081D variantJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 135Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci190017Best OA location URL: https://doi.org/10.1172/jci190017Citation Count: 2
-
OPENTitle: Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 165End Page: 170Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12589Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12589Citation Count: 1
-
OPENTitle: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 156Issue #:Start Page: 105409End Page: 105409Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105409Citation Count: 36
- Serum lipid alterations in GBA-associated Parkinson's disease2017RESTRICTEDTitle: Serum lipid alterations in GBA-associated Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 44Issue #:Start Page: 58End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.026Citation Count: 88
- The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements2016RESTRICTEDTitle: The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurementsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 105Issue #:Start Page: 651End Page: 660Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.01.013Citation Count: 39
- Progressive supranuclear palsy against everyone else: a look into the specificity of MRI markers2025OPENTitle: Progressive supranuclear palsy against everyone else: a look into the specificity of MRI markersJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 478Issue #:Start Page: 123731End Page: 123731Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2025.123731Best OA location URL: https://doi.org/10.1016/j.jns.2025.123731Citation Count: 1
-
OPENTitle: Distinct Roles of the Human Subthalamic Nucleus and Dorsal Pallidum in Parkinson’s Disease ImpulsivityJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 91Issue #: 4Start Page: 370End Page: 379Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.03.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8419208Citation Count: 13
- Disease-modifying therapies for Parkinson's disease2013OPENTitle: Disease-modifying therapies for Parkinson's diseaseJournal Name: The Biomedical & Life Sciences CollectionPublisher: Henry Stewart TalksVol: 2013Issue #: 3Start Page: e1003178End Page: e1003178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.69645/krxj9755Citation Count: 0
- Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI2026RESTRICTEDTitle: Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMIJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78230Citation Count: 0
- Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)2019RESTRICTEDTitle: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050Citation Count: 0
-
OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 981End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 8
- Changes in neuronal activity of cortico‐basal ganglia–thalamic networks induced by acute dopaminergic manipulations in rats2017RESTRICTEDTitle: Changes in neuronal activity of cortico‐basal ganglia–thalamic networks induced by acute dopaminergic manipulations in ratsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 47Issue #: 3Start Page: 236End Page: 250Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.13805Citation Count: 11
-
OPENTitle: MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320aJournal Name: Journal of NeuroimmunologyPublisher: Elsevier BVVol: 278Issue #:Start Page: 185End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jneuroim.2014.11.004Best OA location URL: http://doi.org/10.1016/j.jneuroim.2014.11.004Citation Count: 64
-
OPENTitle: Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brainJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 16Issue #: 40Start Page: 18882End Page: 18898Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d4nr03002hBest OA location URL: http://dx.doi.org/10.1039/d4nr03002hCitation Count: 0
-
OPENTitle: Benzoyl chloride derivatization with liquid chromatography–mass spectrometry for targeted metabolomics of neurochemicals in biological samplesJournal Name: Journal of Chromatography APublisher: Elsevier BVVol: 1446Issue #:Start Page: 78End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.chroma.2016.04.006Best OA location URL: http://doi.org/10.1016/j.chroma.2016.04.006Citation Count: 251
- Acoustic Analysis of Intonation in Persons With Parkinson's Disease Receiving Transcranial Magnetic Stimulation and Intensive Voice Treatment2021RESTRICTEDTitle: Acoustic Analysis of Intonation in Persons With Parkinson's Disease Receiving Transcranial Magnetic Stimulation and Intensive Voice TreatmentJournal Name: Journal of VoicePublisher: Elsevier BVVol: 37Issue #: 2Start Page: 203End Page: 214Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jvoice.2020.12.019Citation Count: 10
- Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program2015RESTRICTEDTitle: Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation ProgramJournal Name: NeuropathologyPublisher: WileyVol: 35Issue #: 4Start Page: 354End Page: 389Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/neup.12189Citation Count: 501
- Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological disease2026RESTRICTEDTitle: Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 18Issue #: 847Start Page: eadz2016End Page: eadz2016Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adz2016Citation Count: 0
- Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetin2013RESTRICTEDTitle: Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetinJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 1816End Page: 1826Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2013.04.010Citation Count: 83
-
OPENTitle: Ligand Dependent Switch from RXR Homo- to RXR-NURR1 HeterodimerizationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 8Issue #: 9Start Page: 2065End Page: 2077Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.7b00216Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.7b00216Citation Count: 27
-
OPENTitle: Parkinson's disease prevalence in Fabry disease: A survey studyJournal Name: Molecular Genetics and Metabolism ReportsPublisher: Elsevier BVVol: 14Issue #:Start Page: 27End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymgmr.2017.10.013Best OA location URL: https://doi.org/10.1016/j.ymgmr.2017.10.013Citation Count: 39
- Dissociation between urate and blood pressure in mice and in people with early Parkinson's disease2018OPENTitle: Dissociation between urate and blood pressure in mice and in people with early Parkinson's diseaseJournal Name: EBioMedicinePublisher: Elsevier BVVol: 37Issue #:Start Page: 259End Page: 268Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2018.10.039Best OA location URL: http://www.thelancet.com/article/S2352396418304572/pdfCitation Count: 9
-
OPENTitle: The Genetic Landscape of Hereditary Spastic Paraplegia in GreeceJournal Name: Clinical GeneticsPublisher: WileyVol: 109Issue #: 5Start Page: 837End Page: 846Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/cge.70113Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cge.70113Citation Count: 0
-
OPENTitle: Identifying the neural correlates of doorway freezing in Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 7Start Page: 2055End Page: 2064Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.24506Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.24506?download=trueCitation Count: 49
- Biopreservation of a tissue engineered nigrostriatal pathway for tract reconstruction in Parkinson’s disease2026RESTRICTEDTitle: Biopreservation of a tissue engineered nigrostriatal pathway for tract reconstruction in Parkinson’s diseaseJournal Name: Acta BiomaterialiaPublisher: Elsevier BVVol: 215Issue #:Start Page: 51End Page: 66Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.actbio.2026.03.031Citation Count: 0
-
OPENTitle: Epidural Spinal Cord Stimulation Improves Motor Function in Rats With Chemically Induced ParkinsonismJournal Name: Neurorehabilitation and Neural RepairPublisher: SAGE PublicationsVol: 33Issue #: 12Start Page: 1029End Page: 1039Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/1545968319876891Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1545968319876891Citation Count: 11
- Targeting LRRK2 mRNA stability in Parkinson’s disease2023RESTRICTEDTitle: Targeting LRRK2 mRNA stability in Parkinson’s diseaseJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 47Issue #: 1Start Page: 1End Page: 3Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tins.2023.10.003Citation Count: 1
-
OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645.2Best OA location URL: https://doi.org/10.7554/elife.91645.2Citation Count: 46
-
OPENTitle: Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/564812Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/564812.pdfCitation Count: 4
- Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD2018RESTRICTEDTitle: Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PDJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 89Issue #: 9Start Page: 989End Page: 994Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2018-318060Citation Count: 80
- Which dyskinesia scale best detects treatment response?2013RESTRICTEDTitle: Which dyskinesia scale best detects treatment response?Journal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 341End Page: 346Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25321Citation Count: 89
-
OPENTitle: Rationally Designed MicroRNA-Based Genetic Classifiers Target Specific Neurons in the BrainJournal Name: ACS Synthetic BiologyPublisher: American Chemical Society (ACS)Vol: 4Issue #: 7Start Page: 788End Page: 795Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acssynbio.5b00040Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4547530Citation Count: 32
-
OPENTitle: The Discovery of Central Nervous System Lymphatic Vessels: The Missing Link That Closes the Circle of Brain ImmunosurveillanceJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 3Issue #: 1Start Page: 29End Page: 30Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12282Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12282Citation Count: 1
-
OPENTitle: Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonistsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 175Issue #: 5Start Page: 782End Page: 796Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.14123Best OA location URL: https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14123Citation Count: 22
- Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study2017RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 13
-
OPENTitle: Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies TreatmentJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 3Start Page: 255End Page: 258Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12611Citation Count: 7
- Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s Disease2018RESTRICTEDTitle: Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 1Start Page: 688End Page: 701Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1109-6Citation Count: 66
-
OPENTitle: Parkinson’s disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron lossJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 10Start Page: 3607End Page: 3622Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaf051Best OA location URL: https://academic.oup.com/brain/article-pdf/148/10/3607/61778148/awaf051.pdfCitation Count: 16
-
OPENTitle: Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 24Issue #:Start Page: 101985End Page: 101985Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101985Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101985Citation Count: 68
- Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease2018RESTRICTEDTitle: Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 50Issue #:Start Page: 104End Page: 107Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.022Citation Count: 347
- Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter2015OPENTitle: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence ReporterJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 5Start Page: 1188End Page: 1197Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/cb5010417Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9927027Citation Count: 56
- PubMedMetaTool: Automated metadata extraction from PubMed using Python for bibliometric analysis2025OPENTitle: PubMedMetaTool: Automated metadata extraction from PubMed using Python for bibliometric analysisJournal Name: Software ImpactsPublisher: Elsevier BVVol: 24Issue #:Start Page: 100766End Page: 100766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.simpa.2025.100766Best OA location URL: https://doi.org/10.1016/j.simpa.2025.100766Citation Count: 1
-
OPENTitle: Reliability of remote video ratings of the scale for assessment and rating of ataxiaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 132Issue #:Start Page: 107278End Page: 107278Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107278Best OA location URL: https://www.prd-journal.com/article/S1353-8020(25)00019-7/pdfCitation Count: 4
-
OPENTitle: Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patientsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.abg3092Best OA location URL: https://doi.org/10.1126/sciadv.abg3092Citation Count: 109
-
OPENTitle: Preparation of S-glycoside surfactants and cysteine thioglycosides using minimally competent Lewis acid catalysisJournal Name: Carbohydrate ResearchPublisher: Elsevier BVVol: 422Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.carres.2015.12.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8876251Citation Count: 19
- Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia2010RESTRICTEDTitle: Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementiaJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 225Issue #: 1Start Page: 210End Page: 218Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.06.017Citation Count: 210
-
OPENTitle: Association of sulfonylureas with the risk of dementia: A population‐based cohort studyJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 71Issue #: 10Start Page: 3059End Page: 3070Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/jgs.18397Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgs.18397Citation Count: 31
-
OPENTitle: Robust and facile purification of full-length, untagged human Nedd4 as a recombinant protein from Escherichia coliJournal Name: Protein Expression and PurificationPublisher: Elsevier BVVol: 173Issue #:Start Page: 105649End Page: 105649Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.pep.2020.105649Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8494286Citation Count: 4
-
OPENTitle: Mapping typical and hypokinetic dysarthric speech production network using a connected speech paradigm in functional MRIJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 27Issue #:Start Page: 102285End Page: 102285Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2020.102285Best OA location URL: https://doi.org/10.1016/j.nicl.2020.102285Citation Count: 10
-
OPENTitle: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 114Issue #: 15Start Page: 3999End Page: 4004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1616874114Best OA location URL: https://www.pnas.org/content/pnas/114/15/3999.full.pdfCitation Count: 84